Erymeto

Pharmacological effects of erythromycin and metoclopramide on gastric retention in ICU patients with and without brain trauma: does the protocol work? - Erymeto

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON58356

Enrollment

1000

Registered

2025-11-19

Start date

2026-02-06

Completion date

Unknown

Last updated

2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Not applicable. Not applicable.

Interventions

Not applicable.

Eligibility

Inclusion criteria

Inclusion criteria: =18 years of age Admitted to ICU Erythromycin and/or metoclopramide is administrated according to gastric retention protocol

Exclusion criteria

Exclusion criteria: Administration of erythromycin and/or metoclopramide for another indication (e.g. gastroscopy or nausea)No gastric retention volume data registered Presence of duodenal feeding tube Patients who have indicated that they object to the use of their data for medical scientific research.

Design outcomes

Primary

Measure	Time frame
The primary analysis involves the delta in gastric retention volume, measured in mL over time.	—

Secondary

Measure	Time frame
Protocol adherence (1 versus 0) Full enteral feeding (yes/no) during the follow up of the protocol Non brain injury patients versus brain injury patients (no/yes)	—

Countries

Netherlands

Contacts

Public ContactE. Haren

Erasmus MC, Universitair Medisch Centrum Rotterdam

e.vanharen@erasmusmc.nl010-704 07 04

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Mar 20, 2026